search

Active clinical trials for "Essential Hypertension"

Results 361-370 of 432

Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine...

Essential Hypertension

To evaluate the efficacy of Amlodipine-folic Acid Tablets on reduction of blood pressure and plasma homocystein.

Unknown status27 enrollment criteria

Treatment of HYpertension: Morning Versus Evening

Essential Hypertension

Rationale: The nocturnal blood pressure mean is an independent and stronger predictor of cardiovascular disease (CVD) risk than either daytime office, awake or 24hour mean blood pressure. In general, when nocturnal blood pressure does not decline CVD risk is higher, usually referred to as "dippers" versus "non-dippers". Evening administration of treatment might lower nocturnal blood pressure more effectively than morning administration, which is most commonly advised. The main hypothesis of this study is that evening administration of antihypertensive medication might resume the dipping pattern in non-dippers and as a consequence might reduce CVD risk more than morning administration. Primary objective (in short): -to prove that evening administration of enalapril/hydrochlorothiazide in non-dippers can resume a dipping blood pressure pattern in non-dippers Study design: A double-blind placebo-controlled cross-over study Each person will use for one period of six weeks enalapril/hydrochlorothiazide in the morning and placebo in the evening, and one period of six weeks the other way around

Unknown status16 enrollment criteria

Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension

Essential Hypertension

The purpose of this study is to assess which drug is more effective of Ramiprin®(ramipril) and Tritace®(ramipril) in the Treatment of Essential Hypertension

Unknown status14 enrollment criteria

GRK4 Polymorphisms Blood Pressure Response to Candesartan

Essential Hypertension

The purpose of this study is to investigate the association between GRK4 polymorphisms and essential hypertension in southwestern Han Chinese and test whether these polymorphisms were associated with the changes in blood pressure in patients with essential hypertension treated with angiotensin II Type antagonist candesartan.

Unknown status4 enrollment criteria

Evaluation of Regional Myocardial Dynamics at Physical Stress in Essential Hypertension

HypertensionLeft Ventricular Hypertrophy

The study hypothesis is stress-related regional tissue dynamics is related to left ventricular outflow tract blood flow.

Completed5 enrollment criteria

Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Early Morning Blood Pressure...

Essential Hypertension

The purpose of this study is to compare nifedipine controlled-release (CR) tablets (Xin Ran) with nifedipine controlled-release tablets (Adalat)in the treatment of Early Morning Blood Pressure and Central Arterial Pressure.

Unknown status21 enrollment criteria

Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function

Coronary Heart DiseaseEssential Hypertension

The Impact of Compound danshen dropping pill for coronary heart disease (CHD) heart and artery structure and function in patients with hypertension

Unknown status1 enrollment criteria

Hybrid Blood Pressure Monitor Validation

Essential Hypertension

Assessment of the accuracy of a Blood Pressure Measuring Device with a digital display-column, NISSEI DM 3000, according to an adaptation of the "European Society of Hypertension International Protocol Revision 2010 for the Validation of Blood Pressure Measuring Devices in Adults".

Completed8 enrollment criteria

Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients...

Essential Hypertension

The aim of the study is to investigate the optimized treatment strategy of hypertension, so as to make more patients to reach the blood pressure goals and to reduce cardio-cerebrovascular events. Objective and Methods: Patients are eligible for inclusion in the study if they are essential hypertension, 50-79 years of age with at least one cardiovascular risk factor and sign the informed consent forms. This project is a multi-centre, prospective randomized,,openlabel blind-endpoint evaluation controlled (PROBE) trial. 12000 patients will be randomly assigned to either of low-dose Amlodipine+Telmisartan group or Amlodipine+ diuretics group. Among those patients with serum cholesterol between 4.0-6.1mmol/L, they will be also randomized into small dose of statin-based regimen or standard management regimen; Patients will also randomly assigned to intensive lifestyle intervention group or standard intervention group according to the community area where the patients in.

Unknown status17 enrollment criteria

An Observational Study to Evaluate Effectiveness and Safety of Amosartan Plus Tablet

Hypertension,Essential

This study was to evaluate the therapeutic effect and safety of Amosartan Plus tablet administration in uncontrolled essential hypertension patients. During the routine medical visit, Amosartan Plus tablets were administered to patients in need of blood pressure control according to the investigator's judgment. In this study, effectiveness and safety information of treatment of Amosartan Plus tablets was followed for 6 months (up to 12 months), and observation of the target patients was terminated after collecting relevant data. As this study was a non-interventional observational study, all patients received prescriptions according to the routine treatment procedure, and there were no visits or procedures required according to the observational study protocol.

Completed4 enrollment criteria
1...363738...44

Need Help? Contact our team!


We'll reach out to this number within 24 hrs